Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis

被引:117
|
作者
Mescam-Mancini, Lenaig [1 ]
Allenbach, Yves [2 ,3 ]
Hervier, Baptiste [2 ,4 ]
Devilliers, Herve [5 ]
Mariampillay, Kuberaka [2 ]
Dubourg, Odile [6 ]
Maisonobe, Thierry [6 ]
Gherardi, Romain [7 ]
Mezin, Paulette [1 ]
Preusse, Corinna [3 ]
Stenzel, Werner [3 ]
Benveniste, Olivier [2 ]
机构
[1] CHU Grenoble, Dept Pathol, Inst Pathol, F-38043 Grenoble, France
[2] Univ Paris 06, Dept Med Interne & Immunol Clin, Ctr Reference Malad Neuromusculaires Paris Est, Hop La Pitie Salpetriere,AP HP,DHU I2B,INSERM UMR, Paris, France
[3] Charite, Dept Neuropathol, D-13353 Berlin, Germany
[4] UPMC, INSERM CIMI Paris, INSERM UMRS 1135, Paris, France
[5] Hop Dijon, Dept Med Interne, Dijon, France
[6] Hop La Pitie Salpetriere, AP HP, Ctr Reference Malad Neuromusculaires Paris Est, Lab Neuropathol, Paris, France
[7] Univ Paris Est Creteil Val de Marne UPEC, INSERM, U955, Inst Mondor Rech Biomed,IFR10, F-94010 Creteil, France
关键词
anti-synthetase; idiopathic inflammatory myopathies; dermatomyositis; polymyositis; necrotizing myopathies; IDIOPATHIC INFLAMMATORY MYOPATHY; ANTISYNTHETASE SYNDROME; AUTOANTIBODIES; IMMUNE; DERMATOMYOSITIS; MUSCLE; CLASSIFICATION; POLYMYOSITIS; FEATURES;
D O I
10.1093/brain/awv192
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Idiopathic inflammatory myopathies can be classified as polymyositis, dermatomyositis, immune-mediated necrotizing myopathy, sporadic inclusion body myositis or non-specific myositis. Anti-Jo-1 antibody-positive patients are assigned to either polymyositis or dermatomyositis suggesting overlapping pathological features. We aimed to determine if anti-Jo-1 antibody-positive myopathy has a specific morphological phenotype. In a series of 53 muscle biopsies of anti-Jo-1 antibody-positive patients, relevant descriptive criteria defining a characteristic morphological pattern were identified. They were tested in a second series of anti-Jo-1 antibody-positive patients and compared to 63 biopsies from patients suffering from other idiopathic inflammatory myopathies. In anti-Jo-1 antibody-positive patients, necrotic fibres, which strongly clustered in perifascicular regions, were frequently observed. Sarcolemmal complement deposition was detected specifically in perifascicular areas. Inflammation was mainly located in the perimysium and around vessels in 90.6%. Perimysial fragmentation was observed in 90% of cases. Major histocompatibility complex class I staining was diffusely positive, with a perifascicular reinforcement. Multivariate analysis showed that criteria defining perifascicular pathology: perifascicular necrosis, atrophy, and perimysial fragmentation allow the distinction of anti-Jo-1 antibody-positive patients, among patients suffering from other idiopathic inflammatory myopathies. Anti-Jo-1 antibody-positive patients displayed perifascicular necrosis, whereas dermatomyositis patients exhibited perifascicular atrophy.
引用
收藏
页码:2485 / 2492
页数:8
相关论文
共 50 条
  • [31] Anti-Jo-1 positive inclusion body myositis with a marked and sustained clinical improvement after oral prednisone
    Hengstman, GJD
    Ter Laak, HJ
    van Engelen, BGM
    Van Venrooij, WJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 70 (05): : 706 - 706
  • [32] Cardiac Involvements in Anti-Mitochondrial Antibody-Positive Myositis
    Maeda, Meiko
    Uesaka, Yoshikazu
    Tsuji, Shoji
    Shimizu, Jun
    NEUROLOGY, 2013, 80
  • [33] Clinical and prognostic associations of anti-Jo-1 antibody levels in patients with antisynthetase syndrome
    Yang, Hongxia
    Chen, Qingning
    Sun, Chao
    Jin, Qiwen
    Zhang, Lining
    Liu, Qingyan
    Peng, Qinglin
    Wang, Guochun
    Lu, Xin
    RESPIRATORY RESEARCH, 2024, 25 (01)
  • [34] IDENTIFICATION AND QUANTITATION OF INDIVIDUAL B-CELLS SECRETING ANTI-JO-1 ANTIBODIES IN PATIENTS WITH MYOSITIS
    LEFF, RL
    NICASTRI, CG
    NICHOLS, RC
    RABEN, N
    PLOTZ, PH
    KLINMAN, D
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S71 - S71
  • [35] DISTINCT SEASONAL PATTERNS IN THE ONSET OF MYOSITIS IN PATIENTS WITH ANTI-JO-1 AND ANTI-SIGNAL RECOGNITION PARTICLE AUTOANTIBODIES
    LEFF, RL
    BURGESS, SH
    MILLER, FW
    LOVE, LA
    JOFFE, MM
    PLOTZ, PH
    CLINICAL RESEARCH, 1990, 38 (02): : A592 - A592
  • [36] Atypical Presentation Of Anti-Jo-1 Positive Interstitial Lung Disease
    Gandhi, V.
    Hewston, M.
    Fasanya, A.
    Sharara, R.
    Cheema, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [37] Primary lung adenocarcinoma associated with anti-Jo-1 positive polymyositis
    Vincze, Melinda
    Molnar, Peter A.
    Zilahi, Erika
    Kapitany, Aniko
    Dezso, Balazs
    Takacs, Istvan
    Danko, Katalin
    JOINT BONE SPINE, 2011, 78 (02) : 209 - 211
  • [38] Activation of the type I interferon system in myositis patients with anti-Jo-1 or Anti-SSA autoantibodies.
    Helmers, Sevim Barbasso
    Eloranta, Maija-Leena
    Ulfgren, Ann-Kristin
    Alm, Gunnar V.
    Rönnblom, Lars
    Lundberg, Ingrid E.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S659 - S659
  • [39] D-PENICILLAMINE AND POLYMYOSITIS - THE SIGNIFICANCE OF THE ANTI-JO-1 ANTIBODY
    JENKINS, EA
    HULL, RG
    THOMAS, AL
    BRITISH JOURNAL OF RHEUMATOLOGY, 1993, 32 (12): : 1109 - 1110
  • [40] IMPROVED DETECTION OF ANTI-JO-1 ANTIBODY, A MARKER FOR MYOSITIS, USING PURIFIED HISTIDYL TRANSFER-RNA SYNTHETASE
    WALKER, EJ
    TYMMS, KE
    WEBB, J
    JEFFREY, PD
    JOURNAL OF IMMUNOLOGICAL METHODS, 1987, 96 (02) : 149 - 156